Irish Tech News – “OncoMark Announces Results of Key Studies on Clinical Performance of Prognostic Test For Early Stage Breast Cancer”

Please link to the article by Cal O’Donnabhain below which was posted in June 2018 by website.

The results of 2 key studies have been released by OncoMark in relation to the clinical performance of it’s OncoMas TR test. The positive results  of both studies show that the OncoMas TR test can accurately identify a significant majority of patients with early stage breast cancer. This would mean these patients would not require chemotherapy as part of their treatment – avoiding unnecessary health risk and costs.

You can access further information by reading the article in full by clicking on the button below.

Share This Post!

Recent Posts

News Archive

If you are interested in becoming an Investor or seeking investment, then please contact us.